MFDS Tightens ZLD Approval With KOLAS TOC Validation

On June 14, 2026, South Korea’s Ministry of Food and Drug Safety (MFDS) updated its ZLD Protocols for Pharma & Biotech Facilities, changing how imported zero liquid discharge systems are accepted for pharmaceutical and biotech facilities. The immediate shift from general third-party test certificates to full-condition TOC removal traceability reports issued by KOLAS-accredited laboratories is especially relevant for equipment exporters, project delivery teams, procurement functions, and Korean project owners reviewing imported ZLD packages.

What the revised protocol now requires

According to the information provided, MFDS updated the relevant ZLD protocol on June 14, 2026. Under the revised requirement, all imported ZLD systems must provide a full-condition traceability verification report for TOC removal efficiency from a KOLAS-accredited laboratory.

This requirement replaces the previous use of third-party testing certificates. The scope covers imported ZLD systems including evaporation and crystallization units, membrane concentration systems, and online TOC monitoring modules.

The new rule took effect immediately on the same day. The provided information also indicates that the change affects the delivery of Chinese ZLD equipment into pharmaceutical projects in South Korea.

Where the pressure is likely to appear first

Imported equipment delivery may face document-driven friction

From an industry perspective, exporters and project delivery teams are likely to feel the impact first because the certification path for imported ZLD systems has changed at the documentation stage. The key issue is not only equipment configuration, but whether the supporting TOC removal verification materials match the new KOLAS traceability requirement.

Procurement reviews may become more focused on compliance readiness

For procurement teams and project buyers, the practical impact may appear in supplier screening, bid clarification, and acceptance review. What deserves closer attention is whether existing suppliers can provide the newly required report format, especially when imported packages include evaporation and crystallization, membrane concentration, and TOC monitoring functions in one delivery scope.

Service and coordination roles may need to manage timing risk

Supply chain coordinators, compliance support providers, and project management teams may also be affected because the rule is already in force. Analysis shows that immediate-effect requirements tend to shift attention toward document completeness, coordination with accredited testing resources, and communication with customers on delivery expectations.

What companies should watch now

Check whether current certificates still meet Korean project needs

The clearest practical issue is that earlier third-party testing certificates are no longer the stated basis under the revised protocol. Companies involved in active or near-term Korea-bound projects should focus on whether current compliance files still support acceptance under the new rule.

Review product scope at the module level

The provided information specifically mentions evaporation and crystallization, membrane concentration, and online TOC monitoring modules. Businesses should therefore pay attention not only to complete systems, but also to how each included module is represented in technical and compliance documentation for Korean deliveries.

Separate policy wording from project execution risk

Observably, the rule change is already clear at the protocol level, but actual project impact may depend on how customers, contractors, and acceptance teams apply the requirement in ongoing deliveries. That makes contract review, document gap checks, and customer communication immediate priorities rather than back-end administrative tasks.

Prepare for customer questions on lead time and proof paths

Because the updated protocol replaces an older certificate route, suppliers and delivery teams should be ready to address questions around report availability, qualification pathways, and any potential effect on handover timing. This is not a prediction of delay, but a practical area where scrutiny is likely to increase.

Why this looks larger than a routine paperwork update

Analysis shows that this development is more than a simple wording change because it shifts the accepted proof standard for imported ZLD systems in a regulated end-use setting. It is more appropriate to understand this as a compliance signal tied to verification quality and traceability, rather than as a narrow document substitution alone.

At the same time, it should not yet be overstated as a final judgment on all project outcomes. Based on the information provided, the confirmed fact is the protocol revision and its immediate effect. The broader commercial impact still requires continued observation through actual procurement, acceptance, and delivery practice.

How to read the update at this stage

At this stage, the MFDS revision is best understood as an immediate compliance change with potential near-term delivery implications for imported ZLD systems serving South Korean pharmaceutical and biotech projects. For the industry, the most rational reading is that proof of TOC removal performance has become a more formal gate in project execution, while the full scale of business impact remains something to watch rather than assume.

Basis of this article and what still needs verification

This article is based on the user-provided news title, event date, and summary concerning the June 14, 2026 MFDS update to the ZLD Protocols for Pharma & Biotech Facilities. For this type of industry development, relevant source categories typically include official government notices, company disclosures, industry association updates, authoritative media coverage, and standard or protocol documents.

A specific official source link was not provided in the input, so the exact source document link still needs to be verified on an ongoing basis. Continued attention should focus on any further official clarification, project-side interpretation, and implementation details affecting imported ZLD system documentation and delivery.